Your browser doesn't support javascript.
loading
Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approach.
Slovin, S F; Livingston, P O; Rosen, N; Sepp-Lorenzino, L; Kelly, W K; Mendelsohn, J; Scher, H I.
Affiliation
  • Slovin SF; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Semin Oncol ; 23(6 Suppl 14): 41-8, 1996 Dec.
Article in En | MEDLINE | ID: mdl-8996585
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Radioimmunotherapy / Receptors, Growth Factor / Immunotherapy / Neoplasms, Hormone-Dependent / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: Semin Oncol Year: 1996 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Radioimmunotherapy / Receptors, Growth Factor / Immunotherapy / Neoplasms, Hormone-Dependent / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: Semin Oncol Year: 1996 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos